Geftinat (Gefitinib) – 250 Mg

Geftinat (Gefitinib) – 250 Mg is an effective treatment for non-small cell lung cancer. With a 250 mg dosage, it inhibits certain proteins that promote cancer cell growth, preventing tumor growth and spread. Clinical studies have shown a 75% response rate and prolonged progression-free survival.